ALLIANCEBERNSTEIN L.P. - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$136,900
+66.7%
74,0000.0%0.00%
Q4 2022$82,140
-48.0%
74,000
+9.5%
0.00%
Q3 2022$158,000
-19.8%
67,600
+3.8%
0.00%
Q2 2022$197,000
-53.3%
65,100
+4.8%
0.00%
Q1 2022$422,000
-18.4%
62,100
+0.3%
0.00%
Q4 2021$517,000
+12.4%
61,9000.0%0.00%
Q3 2021$460,000
+9.3%
61,9000.0%0.00%
Q2 2021$421,000
-26.7%
61,900
+10.7%
0.00%
Q1 2021$574,000
+46.8%
55,9000.0%0.00%
Q4 2020$391,000
-14.3%
55,9000.0%0.00%
Q3 2020$456,000
+16.9%
55,900
-1.1%
0.00%
Q2 2020$390,000
+63.9%
56,500
+12.5%
0.00%
Q1 2020$238,000
-35.3%
50,200
+19.2%
0.00%
Q4 2019$368,000
+162.9%
42,1000.0%0.00%
Q3 2019$140,000
-32.7%
42,1000.0%0.00%
Q2 2019$208,000
-18.8%
42,100
+1.9%
0.00%
Q1 2019$256,000
+84.2%
41,3000.0%0.00%
Q4 2018$139,000
-48.1%
41,3000.0%0.00%
Q3 2018$268,000
-11.8%
41,300
+4.0%
0.00%
Q2 2018$304,000
-23.6%
39,700
+123.0%
0.00%
Q1 2018$398,000
+130.1%
17,800
+30.9%
0.00%
Q4 2017$173,000
-11.7%
13,600
+7.9%
0.00%
Q3 2017$196,000
+10.7%
12,6000.0%0.00%
Q2 2017$177,00012,6000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,087,961$2,012,7281.74%
Opaleye Management Inc. 2,880,000$5,328,0001.60%
TANG CAPITAL MANAGEMENT LLC 5,300,087$9,805,1611.46%
Ardent Capital Management, Inc. 923,463$1,708,4071.23%
Beryl Capital Management LLC 610,831$1,130,0370.89%
Arena Investors LP 610,639$1,129,6820.88%
Omega Fund Management, LLC 275,513$509,6990.33%
Deep Track Capital, LP 4,259,653$7,880,3580.32%
PenderFund Capital Management Ltd. 246,310$6160.19%
GABELLI & Co INVESTMENT ADVISERS, INC. 425,100$786,4350.15%
View complete list of JOUNCE THERAPEUTICS INC shareholders